Teladoc CEO sells 18,327 shares after vesting
Teladoc Health, Inc. (TDOC) reported that Chief Executive Officer and director Charles DiVita III had restricted and performance stock units vest into common stock and sold a portion of shares.
Rhea-AI Filing Summary
Teladoc Health, Inc. (TDOC) reported that Chief Executive Officer and director Charles DiVita III had restricted and performance stock units vest into common stock and sold a portion of shares. On September 1, 2026, 42,277 restricted stock units and 1,966 performance stock units converted one-for-one into common shares. On September 2, 2026, 18,327 common shares were sold at $6.30 per share to cover tax withholding obligations related to these vestings. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
5 txns
Insider
DIVITA CHARLES III
Role
CHIEF EXECUTIVE OFFICER
Sold
18,327 shs ($115K)
Approx. gross sale proceeds
$115K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F3 | 18,327 | $6.301 | $115K |
| Exercise | Restricted Stock Units F1, F4 | 42,277 | $0.00 | $0.00 |
| Exercise | Performance Stock Units F2, F5 | 1,966 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 42,277 | -- | -- |
| Exercise | Common Stock F2 | 1,966 | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 253,662 contracts (Direct);
Performance Stock Units — 11,795 contracts (Direct);
Common Stock — 440,538 shares (Direct)
Footnotes (5)
- F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- F2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- F3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- F4. On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- F5. On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Key Figures
Common shares sold: 18,327 shares
Sale price per share: $6.301 per share
Restricted stock units converted: 42,277 units
+3 more
6 metrics
Common shares sold
18,327 shares
Sale by CEO on September 2, 2026
Sale price per share
$6.301 per share
Sale of 18,327 Teladoc Health common shares
Restricted stock units converted
42,277 units
RSUs converting one-for-one into common stock on September 1, 2026
Performance stock units converted
1,966 units
PSUs converting one-for-one into common stock on September 1, 2026
Restricted stock units remaining
253,662 units
RSU derivative holdings following the September 1, 2026 transaction
Performance stock units remaining
11,795 units
PSU derivative holdings following the September 1, 2026 transaction
Key Terms
Restricted stock units, Performance stock units, tax withholding obligation, substantially equal quarterly installments
4 terms
Restricted stock units financial
"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance stock units financial
"Performance stock units convert to shares of TDOC common stock on a one-for-one basis"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
tax withholding obligation financial
"Shares sold to cover the tax withholding obligation in respect of vesting"
substantially equal quarterly installments financial
"with the remainder vesting in eight substantially equal quarterly installments thereafter"
FAQ
What insider transactions did TDOC’s CEO report on this Form 4?
The CEO, Charles DiVita III, reported vesting of 42,277 restricted stock units and 1,966 performance stock units into Teladoc Health common stock on September 1, 2026, and a sale of 18,327 common shares on September 2, 2026.
What equity awards vested for TDOC’s CEO in this Form 4?
On September 1, 2026, 42,277 restricted stock units and 1,966 performance stock units converted into an equal number of Teladoc Health common shares, consistent with the one-for-one conversion terms disclosed in the footnotes.
Were the TDOC CEO’s transactions under a Rule 10b5-1 trading plan?
No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked and the footnotes do not state that these transactions were made under a Rule 10b5-1 trading plan.
Does the Form 4 show remaining TDOC equity awards for the CEO?
Yes. After the September 1, 2026 conversions, the CEO reports remaining positions of 253,662 restricted stock units and 11,795 performance stock units still outstanding as derivative holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
